DOYLE THOMAS JAMES bought KURA
January 2, 2026 · Form 4 insider transaction
DOYLE THOMAS JAMES bought 42,500 shares of Kura Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,500
Price
$0.00
Total value
N/A
InsiderDOYLE THOMAS JAMES
RoleOfficer
CompanyKura Oncology, Inc. (KURA)
SecurityOption to purchase common stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after42,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests in 48 equal monthly installments commencing on the grant date.